Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Joe Biden raised Canadian Sikh’s death with India’s Narendra Modi at G20
    • The decoy weapons leading Russian forces astray in Ukraine
    • F-35 fighter jets can only fly 55% of time, US watchdog says
    • Russian state TV promotes new Tucker Carlson show
    • US senator Robert Menendez indicted on federal bribery charges
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Jeremy Hunt plans Isa overhaul to boost share ownership
    • Rishi Sunak plans to overhaul A-level system with ‘British baccalaureate’
    • UK recession risk increases as services activity falls
    • UK mortgage rates set to fall after Bank of England knife-edge vote
    • Number of UK nursing students plummets despite NHS shortages
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Asahi chief warns climate change could lead to beer shortages
    • Rupert Murdoch resolves his own succession drama — for now
    • Crispin Odey faces first lawsuit over alleged sexual misconduct
    • US auto strike expands to 38 General Motors and Stellantis facilities
    • Silchester-backed asset management boutique shuts its doors
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • News updates from September 22: US senator Menendez indicted, Bank of Japan maintains ultra-low rates
    • Jeremy Hunt plans Isa overhaul to boost share ownership
    • How Xi Jinping is taking control of China’s stock market
    • Monzo clients rush to sign up for BlackRock offering
    • Russia puts squeeze on oil market with diesel export ban
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Russell Brand learnt his tricks in television studios
    • How to save your state pension
    • Are we destined for a zero-sum future?
    • Lachlan’s accession won’t put an end to Murdoch family strife
    • Populism could derail the green transition
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • ‘There is no work to balance’: how shrinking budgets, Covid and AI shook up life in consulting
    • American Express’s Steve Squeri: ‘If you’re not ready for the upswing, you’ve missed’
    • FT Business Books — what to read this month
    • Can I start a business when I have MS?
    • The plight of the hidden carers in your workforce
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Anna Wintour: ‘I just have to make sure things are being done right’
    • Who’d invite the boss to dinner?
    • John Fetterman, dress codes and American anarchy
    • PowerPoint is widely reviled. How did it triumph?
    • Bosses won’t like it but WFH is a happier way to work
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Johnson & Johnson Co Inc

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Monday, 31 July, 2023
    Lex
    Johnson & Johnson: second talc bankruptcy dismissal hits share price Premium content

    US courts resist financial engineering as fears grow that litigation could continue for years.

    Johnson’s Baby Powder: the J&J subsidiary LTL has been found ‘not sufficiently financially distressed to avail itself of bankruptcy’.
  • Wednesday, 31 May, 2023
    Behind the Money podcast35 min listen
    Best Of: Inside Johnson & Johnson’s bankruptcy two-step

    Is this legal manoeuvre setting a precedent for corporations to evade accountability in America?

  • Friday, 5 May, 2023
    Special ReportAsia-Pacific Innovative Lawyers
    In-house legal work: best practice case studies

    Examples of innovative services and advice developed by legal teams in Asia-Pacific

    5G network communication composite image
  • Thursday, 4 May, 2023
    J&J consumer arm’s shares jump in biggest US IPO since 2021

    Kenvue valued at $41bn after carve-out from US healthcare group

    A bottle of Listerine brand mouthwash, manufactured by Johnson & Johnson’s  consumer arm Kenvue
  • Thursday, 27 April, 2023
    Talcum powder cancer claims target J&J’s new consumer carve-out

    Executives had tried to shield Kenvue from most of the asbestos lawsuits already facing the group

    A container of Johnson & Johnson baby powder
  • Tuesday, 18 April, 2023
    Johnson & Johnson reports loss after taking $6.9bn charge over talc claims

    Healthcare group to ask judge to halt lawsuits over talcum powder linked to cancer under auspices of bankruptcy system

  • Wednesday, 5 April, 2023
    Lex
    Johnson & Johnson: talc settlement shows virtues of Chapter 11 process Premium content

    US bankruptcy may be a tolerable, if imperfect, forum for resolving these cases

    Johnson’s baby powder on a supermarket shelf in Alhambra, California
  • Tuesday, 4 April, 2023
    Johnson & Johnson proposes $8.9bn talc settlement

    Healthcare company tries to put thousands of lawsuits behind it with latest offer to plaintiffs

    Johnson & Johnson company offices in Irvine, California
  • Tuesday, 7 February, 2023
    FT News Briefing podcast9 min listen
    The jig is up for the Texas two-step

    UK to design ‘digital pound’ that could fend off a future private tech rival

  • Monday, 6 February, 2023
    News in-depthBankruptcy
    Talc ruling a blow to J&J and the ‘Texas two-step’ bankruptcy jig

    Ruling by US court will make companies think twice about using Chapter 11 schemes to handle lawsuits

    Containers of  Johnson’s baby powder made by  Johnson & Johnson
  • Tuesday, 31 January, 2023
    Lex
    J&J: court stops the music for the ‘Texas two-step’ Premium content

    Congress may eventually have to step in and create a new club to resolve mass torts

    The Johnson & Johnson logo
  • Monday, 30 January, 2023
    J&J blocked from using bankruptcy to resolve talcum powder lawsuits

    Ruling from US appeals court casts doubt on future of contentious ‘Texas two-step’ manoeuvre

    Johnson’s baby power on display in a store
  • Thursday, 5 January, 2023
    Lex
    J&J/Kenvue: IPO will test investor appetite Premium content

    A successful listing would focus J&J on its pharmaceutical and medical-device business

    J&J has published the prospectus for the demerger of Kenvue
  • Tuesday, 1 November, 2022
    Lex
    J&J/Abiomed: healthcare giant pays high price to bulk up on medtech Premium content

    EV/ebitda multiple is rich, given the healthcare giant expects any potential cost savings to be ‘very modest’

    US flag over Johnson & Johnson’s logo outside the New York Stock Exchange
  • Tuesday, 1 November, 2022
    Johnson & Johnson bucks global M&A slowdown with $16.6bn Abiomed deal

    Purchase of heart pumpmaker to help US pharma group focus on drugs and medical devices

    Johnson’s baby powder on sale at a store in California
  • Tuesday, 25 October, 2022
    The Big Read
    ‘Texas two-step’: the US legal move letting corporations off the hook

    Critics say the controversial legal manoeuvre allows companies to bypass their responsibilities. But judges are beginning to crack down

  • Monday, 22 August, 2022
    J&J tries to extend its ‘Texas two-step’ to halt two states’ talc cases

    New Mexico and Mississippi say consumer company’s strategy is making a ‘mockery’ of bankruptcy law

    J&J’s baby powder
  • Tuesday, 19 July, 2022
    J&J blames US dollar strength for second outlook cut in as many quarters

    Pharmaceutical group issues downbeat forecast despite better than expected quarterly results

    The Johnson & Johnson logo is displayed outside the company’s headquarters in New Brunswick, New Jersey
  • Tuesday, 21 June, 2022
    Behind the Money podcast28 min listen
    Inside Johnson & Johnson’s bankruptcy two-step

    This legal manoeuvre is setting a new precedent for corporations to evade accountability in America

  • Sunday, 6 March, 2022
    J&J targets Chinese biotech deals as western pharma groups look east

    US drugmaker seeks more tie-ups after existing collaboration yields new cancer treatment

    Technicians at a research laboratory prepare Car-T cancer therapy
  • Tuesday, 1 March, 2022
    LexBankruptcy
    US bankruptcy/J&J: new turn for Texas two-step Premium content

    Ruling opens a fresh chapter for resolving US tort cases

    Bottles of Johnson & Johnson’s baby powder
  • Monday, 28 February, 2022
    Health
    US lawmakers plan bill to outlaw ‘Texas two-step’ bankruptcy ploy

    Fight moves to Congress after judge allows J&J to use scheme to help it settle billions in legal claims

    Bottles of Johnson & Johnson’s baby powder
  • Friday, 25 February, 2022
    Johnson & Johnson can proceed with controversial bankruptcy strategy, judge rules

    Decision allows group to use the manoeuvre to manage tens of thousands of claims that its baby talc caused cancer

    Bottles of Johnson & Johnson’s baby powder
  • Monday, 14 February, 2022
    Legal services
    Architects of ‘Texas two-step’ lambast J&J for its use of the manoeuvre

    Lawyer who drafted statute says companies should not deploy it to ‘skirt’ their obligations

  • Thursday, 6 January, 2022
    Covid-19 vaccines
    Covid vaccine makers face investor pressure over global access

    Asset managers call for pharma executive pay to be linked to equitable distribution of jabs

    Moderna Covid vaccines are received at Nairobi airport in Kenya
Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today’s Newspaper (FT Digital Edition)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In